EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma

By Davidson Ben   Goldberg Iris   Berner Aasmund   Kristensen Gunnar   Reich Reuven  

Clinical and Experimental Metastasis, Vol. 20, Iss. 2, 2003-03 ,pp. : 161-169

Springer Publishing Company

Access to resources Recommend Favorite

Expression and clinical significance of extracellular matrix metalloproteinase inducer, EMMPRIN/CD147, in human osteosarcoma

By          

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 201-207

Spandidos Publications

Access to resources Recommend Favorite

Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): Co-expression in metastatic serous ovarian carcinoma

By Davidson Ben   Givant-Horwitz Vered   Lazarovici Philip   Risberg Björn   Nesland Jahn   Trope Claes   Schaefer Erik   Reich Reuven  

Clinical and Experimental Metastasis, Vol. 20, Iss. 7, 2003-11 ,pp. : 621-631

Springer Publishing Company

Access to resources Recommend Favorite

Study on extracellular matrix metalloproteinase inducer and human epidermal growth factor receptor2 protein expression in papillary thyroid carcinoma using a quantum dotbased immunofluorescence technique

By    

Experimental and Therapeutic Medicine, Vol. 9, Iss. 4, 2015-01 ,pp. : 1331-1335

Spandidos Publications

Access to resources Recommend Favorite

Extracellular Matrix Metalloproteinase Inducer is a Negative Prognostic Factor of Pediatric Medulloblastoma

By Chu Tongwei  

Pathology & Oncology Research, Vol. 17, Iss. 3, 2011-09 ,pp. : 705-711

Springer Publishing Company

Access to resources Recommend Favorite